Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
Yimin Liang, Shijie Su, Zhaoxia Lun, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12

Showing 12 citing articles:

Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
Xiangying Yan, Yudong Liu, Congchong Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Immunomodulation of cuproptosis and ferroptosis in liver cancer
Jia-qian Mo, S. Zhang, Qiang Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
The E3 ligase TRIM7 suppresses the tumorigenesis of gastric cancer by targeting SLC7A11
Qishuai Chen, Tong-Tong Zhang, Runzhi Zeng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Glutaminolysis of CD4+ T Cells: A Potential Therapeutic Target in Viral Diseases
Yushan Xu, Miaomiao Li, Mengjiao Lin, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 603-616
Open Access | Times Cited: 6
The current status and future of PD-L1 in liver cancer
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Research of SLC7A11 to estimate the prognosis and immune infiltration landscape for breast cancer
Xiangjie Xue, Yicheng Zhi, Lu Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Integrative Disulfidptosis‐Based Risk Assessment for Prognostic Stratification and Immune Profiling in Glioma
Xiaowang Niu, Guangzhao Li, Ulf D. Kahlert, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access
Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study
Maria Beatrice Morelli, Andrea Spinaci, Chang Cui, et al.
FEBS Open Bio (2025)
Open Access
Research progress of ferroptosis regulating lipid peroxidation and metabolism in occurrence and development of primary liver cancer
Yu-Jie Shu, B. Lao, Ying-Yang Qiu
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 6, pp. 2335-2349
Open Access | Times Cited: 2
PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma
Decheng Li, Meiling Wan, Xiaoling Liu, et al.
Aging (2024)
Open Access | Times Cited: 1
Up-regulated ORC1 promotes lung adenocarcinoma by inhibiting ferroptosis via SLC7A11 dependent pathway
Linlin Ming, Zhendong Han, Zhongwei Ai, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30506-e30506
Open Access
Upregulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity
Shawn Lu Wen Tan, Hui Min Tan, Erez Israeli, et al.
Biochemical Journal (2023) Vol. 480, Iss. 24, pp. 2045-2058
Open Access
Page 1

Scroll to top